Longitudinal association of C-reactive protein and Haemoglobin A1c over 13 years: the European Prospective Investigation into Cancer - Norfolk study
Open accessThe DOI matches its Crossref record; 33 of the 34 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Type-2 diabetes is associated with systemic inflammation and higher C-reactive protein (CRP) levels. However, the longitudinal association of CRP and haemoglobin-A1c (HbA1c) has not been described in large prospective studies. Understanding such associations may shed light on the role of inflammation in development of type-2 diabetes and its complications such as cardiovascular diseases. METHODS: EPIC-Norfolk is a cohort study of men and women aged 40-79 years at time of recruitment (1993-1997). Serum CRP (mg/l) was measured using a high-sensitivity assay at baseline and 13-years follow-up. HbA1c (%) was measured at baseline, 4, and 13 years. Participants were excluded if they were diagnosed with diabetes or were taking diabetes medication. Data on at least one measurement of CRP and HbA1c was available for 14228 participants (55 % of the cohort). RESULTS: In the cross-sectional analysis of baseline data, a 1-SD higher loge-CRP (about three-fold higher CRP) was associated with 0.06 (95 % CI 0.04, 0.08) higher HbA1c (%) adjusted for potential confounders. In longitudinal analysis using multivariable linear mixed models, change in CRP over 13 years was to a similar extent positively associated with increase in HbA1c, such that 1-SD higher longitudinal change in loge-CRP was associated with 0.04 (95 % CI 0.02, 0.05) increase in HbA1c. CONCLUSION: In this study we found longitudinal observational evidence suggesting that increase in systemic inflammation is associated with an increase in HbA1c and thus systemic inflammation may have a role in development of type-2 diabetes and its complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Our findings are consistent with those from a longitudinal observational study in patients without diabetes, which found that there was a positive association between HbA1c and hsCRP levels [45].”
From Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials (2022) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“TNF-α is suggested to induce insulin resistance [17].”
Background(2010) · The Lancet · doi:10.1016/s0140-6736(09)61717-7 · Cited by 2,546 · cited 1×
“Similar results were reported in other studies [10, 15].”
ResultWareham, N. J., Jakes, R. W., Rennie, K. L., Schuit, J., Mitchell, J., Hennings, S., & Day, N. E. (2003) · Public Health Nutrition · doi:10.1079/phn2002439 · Cited by 850
Self-citationInflammatory Markers and Risk of Type 2 Diabetes
Wang, X., Bao, W., Liu, J., OuYang, Y.-Y., Wang, D., Rong, S., Xiao, X., Shan, Z.-L., Zhang, Y., Yao, P., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0702 · Cited by 820
Day, N., Oakes, S., Luben, R., Khaw, K., Bingham, S., Welch, A., & Wareham, N. (1999) · Nature · doi:10.17863/cam.89388 · Cited by 780
Self-citationC-reactive protein: Ligands, receptors and role in inflammation
Marnell, L., Mold, C., & Du Clos, T. W. (2005) · Clinical Immunology · doi:10.1016/j.clim.2005.08.004 · Cited by 627
Franceschi, C., Bonafè, M., & Valensin, S. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00513-7 · Cited by 495
Inflamm‐ageing and lifelong antigenic load as major determinants of ageing rate and longevity
De Martinis, M., Franceschi, C., Monti, D., & Ginaldi, L. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.055 · Cited by 492
Inflammation markers predicting frailty and mortality in the elderly
De Martinis, M., Franceschi, C., Monti, D., & Ginaldi, L. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2005.11.004 · Cited by 345
Morohoshi, M., Fujisawa, K., Uchimuraa, I., & Numano, F. (1996) · Diabetes · doi:10.2337/diab.45.7.954 · Cited by 281
Cited by
Mosenzon, O., Capehorn, M. S., De Remigis, A., Rasmussen, S., Weimers, P., & Rosenstock, J. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01585-7 · Cited by 91
Anti-inflammatory properties of antidiabetic drugs: a “promised land” in the COVID-19 era?
Katsiki, N., & Ferrannini, E. (2020) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2020.107723 · Cited by 91
Tong, K. I., Hopstock, L. A., & Cook, S. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-070284 · Cited by 19
Gala, T. D. L. H., Herder, C., Rutters, F., Carstensen‐Kirberg, M., Huth, C., Stehouwer, C. D. A., Nijpels, G., Schalkwijk, C. G., Flyvbjerg, A., Franks, P. W., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3063 · Cited by 13
Xu, R., Jiang, X., Fan, Z., Wan, Y., & Gao, X. (2020) · Nutrition & Metabolism · doi:10.1186/s12986-020-00472-w · Cited by 12
Metadata
- Authors
- Ahmadi-Abhari, S., Kaptoge, S., Luben, R. N., Wareham, N. J., & Khaw, K.-T.
- Affiliations
- University of Cambridge (GB)
- Wellcome/MRC Institute of Metabolic Science (GB)
- Venue
- Cardiovascular Diabetology
- Published
- 2015-05-22
- Volume
- 14
- Issue
- 1
- Pages
- 61-61
- ISSN
- 1475-2840 (ISSN-L)
- PMC
- PMC4445808
- OpenAlex
- W1512417339
- Cited by
- 14
- References
- 34
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 5 · 2021: 1 · 2020: 3 · 2019: 1 · 2018: 1 · 2016: 1
- FWCI
- 0.52
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cardiovascular Diabetology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Apollo
- Funders
- Cancer Research UK
- National Institute for Health and Care Research (NF-SI-0512-10165, NF-SI-0512-10114, NF-SI-0512-10135)
- British Heart Foundation (RG/08/014/24067)
- Medical Research Council (MR/L003120/1, MC_UU_12015/1)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Keywords
- C-reactive protein, HbA1c, systemic inflammation, type 2 diabetes, longitudinal change, EPIC-Norfolk cohort, diabetes complications, cardiovascular disease
- MeSH terms
- Adult, Aged, Aged, 80 and over, C-Reactive Protein, Cross-Sectional Studies, Diabetes Mellitus, Type 2, Europe, Female, Glycated Hemoglobin, Humans, Inflammation, Longitudinal Studies, Male, Middle Aged, Prospective Studies, Cohort Studies, Linear Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Longitudinal association of C-reactive protein and Haemoglobin A1c over 13 years: the European Prospective Investigation into Cancer - Norfolk study. https://app.cochat.ai/papers/10.1186/s12933-015-0224-1
- The paper
- Ahmadi-Abhari, S., Kaptoge, S., Luben, R. N., Wareham, N. J., & Khaw, K.-T. (2015). Longitudinal association of C-reactive protein and Haemoglobin A1c over 13 years: the European Prospective Investigation into Cancer - Norfolk study. Cardiovascular Diabetology. https://doi.org/10.1186/s12933-015-0224-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.